Association of serum microRNA expression in hepatocellular carcinomas treated with transarterial chemoembolization and patient survival

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Liu, Mei ^a   Liu, Jibing ^b   Wang, Liming ^c   Wu, Huiyong ^b   Zhou, Changchun ^b   Zhu, Hongxia ^a   Xu, Ningzhi ^a   Xie, Yinfa ^b  

^a CANCER HOSPITAL   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^c PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; MICRORNA; MICRORNA 101 3P; MICRORNA 122; MICRORNA 199A 5P; MICRORNA 19A; MICRORNA 200A; MICRORNA 21; MICRORNA 214; MICRORNA 221; MICRORNA 222; MICRORNA 223; MICRORNA 224 5P; RNA; UNCLASSIFIED DRUG; TUMOR MARKER;

ACCURACY; ADULT; ARTICLE; BLOOD LEVEL; CANCER PROGNOSIS; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; HUMAN; LIVER CELL CARCINOMA; LIVER NODULE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RELIABILITY; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; SYNDROME DELINEATION; TUMOR VOLUME; BLOOD; CARCINOMA, HEPATOCELLULAR; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; LIVER; LIVER NEOPLASMS; METABOLISM; PATHOLOGY; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC;

BIOMARKERS, TUMOR; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; ROC CURVE;

EID: 84907487771     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109347     Document Type: Article

References (35)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Llovet JM, Real MI, Montana X, Planas R, Coll S, et al. (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial. Lancet 359: 1734-1739.
3. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
4. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518.
5. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, et al. (2005) Silencing of microRNAs in vivo with 'antagomirs'. Nature 438: 685-689.
6. Elmen J, Lindow M, Schutz S, Lawrence M, Petri A, et al. (2008) LNA-mediated microRNA silencing in non-human primates. Nature 452: 896-899.
7. Park JK, Kogure T, Nuovo GJ, Jiang J, He L, et al. (2011) miR-221 silencing blocks hepatocellular carcinoma and promotes survival. Cancer Res 71: 7608- 7616.
8. Negrini M, Gramantieri L, Sabbioni S and Croce CM (2011) microRNA involvement in hepatocellular carcinoma. Anticancer Agents Med Chem 11: 500-521.
9. Ferracin M, Veronese A and Negrini M (2010) Micromarkers: miRNAs in cancer diagnosis and prognosis. Expert Rev Mol Diagn 10: 297-308.
10. Minguez B and Lachenmayer A (2011) Diagnostic and prognostic molecular markers in hepatocellular carcinoma. Dis Markers 31: 181-190.
11. Tsai WC, Hsu PW, Lai TC, Chau GY, Lin CW, et al. (2009) MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology 49: 1571-1582.
12. Coulouarn C, Factor VM, Andersen JB, Durkin ME and Thorgeirsson SS (2009) Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene 28: 3526- 3536.
13. Fornari F, Gramantieri L, Ferracin M, Veronese A, Sabbioni S, et al. (2008) MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene 27: 5651-5661.
14. Gramantieri L, Fornari F, Ferracin M, Veronese A, Sabbioni S, et al. (2009) MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. Clin Cancer Res 15: 5073-5081.
15. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, et al. (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-658.
16. Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, et al. (2006) Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 25: 2537-2545.
17. Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S, et al. (2007) Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 67: 6092-6099.
18. Jiang J, Gusev Y, Aderca I, Mettler TA, Nagorney DM, et al. (2008) Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res 14: 419-427.
19. Han ZB, Zhong L, Teng MJ, Fan JW, Tang HM, et al. (2012) Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation. Mol Oncol 6: 445-457.
20. Farinati F, Marino D, De Giorgio M, Baldan A, Cantarini M, et al. (2006) Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither? Am J Gastroenterol 101: 524-532.
21. Wang Y, Chen Y, Ge N, Zhang L, Xie X, et al. (2012) Prognostic significance of alpha-fetoprotein status in the outcome of hepatocellular carcinoma after treatment of transarterial chemoembolization. Ann Surg Oncol 19: 3540-3546.
22. Riaz A, Ryu RK, Kulik LM, Mulcahy MF, Lewandowski RJ, et al. (2009) Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: oncologic marker of radiologic response, progression, and survival. J Clin Oncol 27: 5734-5742.
23. Kojima K, Takata A, Vadnais C, Otsuka M, Yoshikawa T, et al. (2011) MicroRNA122 is a key regulator of alpha-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma. Nat Commun 2: 338.
24. Au V, Tsang FH, Man K, Fan ST, Poon RT, et al. (2014) Expression of ankyrin repeat and SOCS box containing 4 (ASB4) confers migration and invasion properties of hepatocellular carcinoma cells. Biosci Trends 8: 101-110.
25. Hung CS, Liu HH, Liu JJ, Yeh CT, Chang TC, et al. (2013) MicroRNA-200a and -200b mediated hepatocellular carcinoma cell migration through the epithelial to mesenchymal transition markers. Ann Surg Oncol 20 Suppl 3: S360-368.
26. Petrelli A, Perra A, Cora D, Sulas P, Menegon S, et al. (2014) MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC). Hepatology 59: 228-241.
27. Dhayat SA, Mardin WA, Kohler G, Bahde R, Vowinkel T, et al. (2014) The microRNA-200 family-A potential diagnostic marker in hepatocellular carcinoma? J Surg Oncol 110: 430-438.
28. Callegari E, Elamin BK, Sabbioni S, Gramantieri L and Negrini M (2013) Role of microRNAs in hepatocellular carcinoma: A clinical perspective. Onco Targets Ther 6: 1167-1178.
29. Buscaglia LE and Li Y (2011) Apoptosis and the target genes of microRNA-21. Chin J Cancer 30: 371-380.
30. Wang Y, Gao X, Wei F, Zhang X, Yu J, et al. (2014) Diagnostic and prognostic value of circulating miR-21 for cancer: A systematic review and meta-analysis. Gene 533: 389-397.
31. Zhang Y, Jia Y, Zheng R, Guo Y, Wang Y, et al. (2010) Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin Chem 56: 1830-1838.
32. Xu J, Wu C, Che X, Wang L, Yu D, et al. (2011) Circulating microRNAs, miR- 21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol Carcinog 50: 136-142.
33. Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, et al. (2009) Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci U S A 106: 4402-4407.
34. Li Q, Wang G, Shan JL, Yang ZX, Wang HZ, et al. (2010) MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion. J Gastroenterol Hepatol 25: 164-171.
35. Li Q, Ding C, Chen C, Zhang Z, Xiao H, et al. (2013) miR-224 promotes cell migration and invasion by modulating p-PAK4 and MMP-9 via targeting HOXD10 in human hepatocellular carcinoma. J Gastroenterol Hepatol.